[Federal Register Volume 78, Number 184 (Monday, September 23, 2013)]
[Notices]
[Page 58320]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-22992]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
USC, as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable materials, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel GOMED: Grand Opportunity in Medications Development 
for Substance-Related Disorders (U01).
    Date: October 15, 2013.
    Time: 9:00 a.m. to 11:00 a.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Garden Inn Washington, DC/Bethesda, 7301 Waverly 
Street, Bethesda, MD 21045.
    Contact Person: Jose F. Ruiz, Ph.D., Scientific Review Officer, 
Office of Extramural Affairs, National Institute on Drug Abuse, NIH, 
Room 4228, MSC 9550, 6001 Executive Blvd., Bethesda, MD 20892-9550, 
(301) 451-3086, [email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel Strategic Alliances for Medications Development to 
Treat Substance Use Disorders (R01) (PAS-12-122).
    Date: October 15, 2013.
    Time: 11:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Garden Inn Washington, DC/Bethesda, 7301 Waverly 
Street, Bethesda, MD 21045.
    Contact Person: Jose F. Ruiz, Ph.D., Scientific Review Officer, 
Office of Extramural Affairs, National Institute on Drug Abuse, NIH, 
Room 4228, MSC 9550, 6001 Executive Blvd., Bethesda, MD 20892-9550, 
(301) 451-3086, [email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Medications Development Centers of Excellence 
Cooperative Program.
    Date: October 15-16, 2013.
    Time: 2:00 p.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Garden Inn Washington, DC/Bethesda, 7301 Waverly 
Street, Bethesda, MD 21045.
    Contact Person: Jose F. Ruiz, Ph.D., Scientific Review Officer, 
Office of Extramural Affairs, National Institute on Drug Abuse, NIH, 
Room 4228, MSC 9550, 6001 Executive Blvd., Bethesda, MD 20892-9550, 
(301) 451-3086, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: September 17, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-22992 Filed 9-20-13; 8:45 am]
BILLING CODE 4140-01-P